Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Dynavax Technologies Corp. shares valued at $262,322 were sold by Burgess Justin on Mar 01 ’24. At $12.78 per share, Burgess Justin sold 20,526 shares. The insider’s holdings dropped to 0 shares worth approximately $0.0 following the completion of this transaction.
Also, Janssen Robert sold 1,500 shares, netting a total of over 22,500 in proceeds. Following the sale of shares at $15.00 each, the insider now holds 49,925 shares.
Before that, Novack David F had sold 9,000 shares from its account. In a trade valued at $130,050, the President & COO traded Dynavax Technologies Corp. shares for $14.45 each. Upon closing the transaction, the insider’s holdings decreased to 9,000 shares, worth approximately $36427.409999999996.
As published in their initiating research note from Goldman on February 01, 2024, Dynavax Technologies Corp. [DVAX] has been a Neutral and the price target has been revised to $20. Analysts at JMP Securities started covering the stock with ‘”a Mkt outperform”‘ outlook in a report released in late September. Earlier on August 06, 2021, Goldman initiated its rating. Their recommendation was “a Buy” for DVAX stock.
Analyzing DVAX Stock Performance
During the last five days, there has been a drop of approximately -4.35%. Over the course of the year, Dynavax Technologies Corp. shares have dropped approximately -18.24%. Shares of the company reached a 52-week high of $15.01 on 01/04/24 and a 52-week low of $11.34 on 04/17/24. A 50-day SMA is recorded $12.40, while a 200-day SMA reached $13.56. Nevertheless, trading volume fell to 2.55 million shares from 1.9 million shares the previous day.
Support And Resistance Levels for Dynavax Technologies Corp. (DVAX)
According to the 24-hour chart, there is a support level at 11.32, which, if violated, would cause prices to drop to 11.22. In the upper region, resistance lies at 11.55. The next price resistance is at 11.67. RSI (Relative Strength Index) is 28.97 on the 14-day chart, showing oversold technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.47, which suggests the price will decrease in the coming days. Percent R is at 92.88%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.
Which companies own the most shares of Dynavax Technologies Corp. (DVAX)?
On August 07, 2020, H.C. Wainwright assigned a price target of “a Buy” to the stock and reiterated coverage with a $12.
